Rapid Micro Biosystetms - Pharmaceutical Technology

Latest Issue

Latest Issue
PharmTech Europe

With offices in the US and Europe, Rapid Micro Biosystems has a singular focus on providing businesses a technology for automated rapid detection through the Growth Direct™ System.

The Growth Direct™ System, by Rapid Micro Biosystems, automates the detection and enumeration of colonies in microbial quality control in manufacturing.  The system includes 2 incubators, robotics and imaging systems that detect and enumerate microbial growth in about half the time of the traditional method.  By using the natural autoflouresence of living cells, the system “sees” colonies forming at about 100 cells, far sooner than the human eye. This allows the technology to provide results in about half the time of the traditional method while preserving the colony.

The Growth Direct™ System is designed to be a single test method for use with all the key tests in the microbial quality control lab including bioburden testing, environmental monitoring and sterility testing.  Sample preparation closely matches the existing tests, simplifying training of technicians. The technology can support all tests within one instrument, or each test within a separate unit.

Contact Details:

Company Name: Rapid Micro Biosystems
Address: One Oak Park Drive, Bedford, MA (USA)
Tel: +1 781 271 1444
Fax: +1 781 271 9905
Web: www.rapidmicrobio.com
Contact: Mark Severns
Email: sales@rapidmicrobio.com

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
| Weekly

FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race
FindPharma Custom Search

Click here